03/10/2025
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
03/10/2025
3:52 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
03/06/2025
4:32 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:10 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:54 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:06 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/26/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
4:24 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:42 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NAMSW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. |
01/29/2025
4:25 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:16 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:09 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:52 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Somaiya Mayur Ian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
3:26 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:27 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:58 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:03 PM | Lewis William (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:08 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:09 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:57 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:08 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:10 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:29 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2025
4:57 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:53 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:54 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:56 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:25 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
Trump Shock to change everything (Ad) Is this Trump’s next major move?
Millionaire trading expert Imre Gams has found a bill that directs the United States Treasury to initiate a plan to buy one of the world’s most controversial assets.
If the bill makes it to the desk of Donald Trump it could move $15 trillion out of gold, stocks, and real estate…
And INTO a tiny corner of the markets few truly understand.  Click here to see how to prepare today. |
12/17/2024
4:05 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
12/17/2024
9:28 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
12/16/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:28 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:33 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
12/12/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:57 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-3MEF | |
12/10/2024
3:48 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
12/10/2024
6:24 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:07 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:29 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
11/14/2024
4:46 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:02 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 20-F/A | |
10/18/2024
3:51 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:01 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:23 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:12 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:22 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:20 PM | AMGEN INC (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13G/A | |
08/22/2024
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
08/09/2024
4:21 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
08/09/2024
4:23 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:24 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
08/07/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
7:30 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:30 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2024
3:30 PM | Joustra Wouter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2024
3:31 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
7:10 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
07/03/2024
3:34 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
3:31 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/24/2024
7:30 AM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
7:12 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:18 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form ARS | |
05/09/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
04/17/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
04/12/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
04/12/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
04/01/2024
7:16 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
4:37 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
March 18th: Gold SHOCK? (Ad)
On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic… Businesses could get blindsided… The gold market could get rocked… And one man, millionaire trader Jeff Clark is pounding the table on one single stock before this event. Because this one single stock has shown his readers gains of 85% in 14 days, 120% in under 3 months, and even 222% in just 8 days. While the past is no sure indicator for the future… Those gains could pale in comparison to what's coming. Click here now to see what's going on |
03/12/2024
3:18 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
